Journal IJCRT UGC-CARE, UGCCARE( ISSN: 2320-2882 ) | UGC Approved Journal | UGC Journal | UGC CARE Journal | UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, International Peer Reviewed Journal and Refereed Journal, ugc approved journal, UGC CARE, UGC CARE list, UGC CARE list of Journal, UGCCARE, care journal list, UGC-CARE list, New UGC-CARE Reference List, New ugc care journal list, Research Journal, Research Journal Publication, Research Paper, Low cost research journal, Free of cost paper publication in Research Journal, High impact factor journal, Journal, Research paper journal, UGC CARE journal, UGC CARE Journals, ugc care list of journal, ugc approved list, ugc approved list of journal, Follow ugc approved journal, UGC CARE Journal, ugc approved list of journal, ugc care journal, UGC CARE list, UGC-CARE, care journal, UGC-CARE list, Journal publication, ISSN approved, Research journal, research paper, research paper publication, research journal publication, high impact factor, free publication, index journal, publish paper, publish Research paper, low cost publication, ugc approved journal, UGC CARE, ugc approved list of journal, ugc care journal, UGC CARE list, UGCCARE, care journal, UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, ugc care list of journal, ugc care list 2020, ugc care approved journal, ugc care list 2020, new ugc approved journal in 2020, ugc care list 2021, ugc approved journal in 2021, Scopus, web of Science.
How start New Journal & software Book & Thesis Publications
Submit Your Paper
Login to Author Home
Communication Guidelines

WhatsApp Contact
Click Here

  Published Paper Details:

ugc approved journal, UGC CARE Journal, ugc approved list of journal, ugc care journal, UGC CARE list, UGC-CARE, care journal, UGC-CARE list, Journal publication, ISSN approved, Research journal, research paper, research paper publication

  Authors

Prem Lata,Kirti Kaushal,Shalini Vashisht,Jyoti Gupta

  Keywords

Coronavirus, Pandemic, Communicable disease, Vaccine.

  Abstract


The sudden pandemic among several communicable diseases is having an extremely damaging effect mostly on lives of hundreds of thousands of individuals. These conditions have put a lot of pressure on our medical system and other basic public services, but they have also put pressure on the economy, researchers, and governments as they work to find responses to the economic crisis, develop vaccines, and maintain community expectations, appropriately. The most common infections that really can damage anyone, no matter their gender or age, are acute respiratory tract infections (ARTIs). Before the biggest Chinese celebration at the end of the year, a variety of dangerous diseases attacked. Our capacity to fight the threat of highly contagious viruses, mainly coronaviruses, which are known to be highly dangerous to human beings,has been challenged by one of the most current ARTI (acute respiratory tract infection) using such, COVID-19. Even though the coronavirus has already been identified disease since 1960s. SARS-CoV-2 is actually a part of the Coronaviridae family, which is a subdivision of the Nidovirales order. Although such a pharmaceutical cannot currently successfully treat COVID-19, broad-spectrum antivirals and other medications are showing some promise in treating SARS-CoV-2 infections. More than 15 different medications were employed in order to investigate actual identification of COVID-19 infections.Like bevacizumab, fluvoxamine, lopinavir, ritonavir, tocilizumab, and sarilumab. Patients having COVID-19 have just a wide range of challenges due to the absence of effective medicine to deal with the problem. As the population is growing, medications will be essential in the hopes of maintaining and minimizing the financial damage imposed on by the disease. Common human coronaviruses, such as subtypes 229E, NL63, OC43, and HKU1, were also generally responsible for the prevalent cold as well as other mild to moderate upper respiratory tract symptoms. Usually people contract this virus at some period within their lifetimes. Normally, these symptoms last for two weeks. Human coronaviruses were generally spread because of an infected person sneezing and coughing towards people who inhaled in the air. Avoid travelling, Wash your hands properly and apply sanitizer,During cough and sneezing use mask.

  IJCRT's Publication Details

  Unique Identification Number - IJCRT2304361

  Paper ID - 234348

  Author type - Indian Author

  Page Number(s) - d45-d53

  Pubished in - Volume 11 | Issue 4 | April 2023

  DOI (Digital Object Identifier) -   

  No Of Downloads - 140

  Author Country - India, -, -, -, -, Science and Technology

  Publisher Name - IJPUBLICATION | www.ijcrt.org | ISSN : 2320-2882

  E-ISSN Number - 2320-2882

  Published Paper PDF : - http://www.ijcrt.org/papers/IJCRT2304361

  Published Paper URL: : - http://ijcrt.org/viewfull.php?&p_id=IJCRT2304361

  Published Paper PDF Downlaod: - download.php?file=IJCRT2304361

  Cite this article

Prem Lata,Kirti Kaushal,Shalini Vashisht,Jyoti Gupta,   "A REVIEW ON: CORONAVIRUS OUTBREAKS", International Journal of Creative Research Thoughts (IJCRT), ISSN:2320-2882, Volume.11, Issue 4, pp.d45-d53, April 2023, Available at :http://www.ijcrt.org/papers/IJCRT2304361.pdf

  Share this article

  Article Preview

  Types of Articles invited

Research Papers, Survey Papers, Study Papers, Subjective Papers, Experimental Result Papers, Analysis Study Research Papers, Informative Article, Comparison Papers, Case Studies Papers, Review Papers, Comparative Studies, Dissertation Chapters, Research Proposals or Synopsis, Working Projects, New Innovation & Idea, Prototypes and Models and many More

  Call For Paper

  About IJCRT (Refereed Journal, Peer Journal and Indexed Journal )

About IJCRT

The International Journal of Creative Research Thoughts (IJCRT) aims to explore advances in research pertaining to applied, theoretical and experimental Technological studies. The goal is to promote scientific information interchange between researchers, developers, engineers, students, and practitioners working in and around the world.

IJCRT is Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool), Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

The open access supports the rights of users to read, download, copy, distribute, print, search, or link to the full texts of these articles provided they are properly acknowledged and cited.


Indexing In Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar | AI-Powered Research Tool, Microsoft Academic, Academia.edu, arXiv.org, Research Gate, CiteSeerX, ResearcherID Thomson Reuters, Mendeley : reference manager, DocStoc, ISSUU, Scribd, and many more

International Journal of Creative Research Thoughts (IJCRT)
ISSN: 2320-2882 | Impact Factor: 7.97 | Impact Factor: 7.97 and Monthly-Peer-reviewed, and Refereed Journals.
Open Access Processing Charges or Publication fees with free DOI : ₹1500 INR for Indian author & 55$ for foreign International author.

Refereed Journal, Peer Journal and Indexed Journal
Publication Issue Frequency : Monthly (12 issue Per Year Annually)
Journal Discipline and Subject : Multidisciplinary,Monthly,Multilanguage (Regional language supported) .
Publisher and Managed By : IJPUBLICATION (ijpublication.org).
Publication Supported Languages: Allow All Multiple Languages (Regional language supported).


Provide DOI and Hard copy of Certificate.
High impact factor and 50+ index database and Fast paper publication.
Nominal Fee for Professional Research Services, Low cost research journal.
Publication Guidelines : COPE Guidelines
Quick, Fast, automatic Speedy Review and publication Process
Notification of Review Result and publication - Within 02-03 Days.
Provide Free e-certificate to all author and DOI (Digital Object Identifiers) to All Paper.
Download all digital data from website anytime lifetime available.
Indexing of paper in all major online journal databases.

Low Publication Charge 1500 INR per single paper Publication with Maximum 5 Author for indian author & 55$ for foreign International author.

Paper Submission Till : 29 July 2024
Review Results (Acceptance/Rejection) Notification : Within 02-03 Days
Paper Publication Time : Paper Publish: Within 02-03 Days after submitting all the required documents.

Submit your Paper Submit your paper


Call For Paper (Volume 12 | Issue 7 | Month- July 2024)

Licence and Indexing

Indexing In Google Scholar, ResearcherID Thomson Reuters, Mendeley : reference manager, Academia.edu, arXiv.org, Research Gate, CiteSeerX, DocStoc, ISSUU, Scribd, and many more | High Impact Factor: 7.97 | Digital object identifier (DOI) and Hard Copy of certificate Provided.







Licence

DOIIJCRT Research Journal
ISSN Approved
Impact Factor: 7.97 IJCRT Research Journal
Creative Common IJCRT Research Journal
Valid as per new UGC Gazette regulations IJCRT Research Journal

Features

Impact Factor: 7.97 and ISSN approved.
Impact Factor: 7.97 Calculated by google scholar
Call For Paper (Volume 12 | Issue 7 | Month- July 2024)
Quick, Fast, automatic Speedy Review Process
Notification of Review Result - Within 02-03 Days.
Publication of Paper - Within 02-03 Days.

Provide Free DOI(Digital Object Identifiers) to All Paper.
Provide Hard copy of certificate based on request.
Indexing of paper in all major online journal databases.
SEO effective and Automated Metadata Citation Generator.

Open-Access peer reviewed International Journal
Fully Automated and Secure https Website
Author can Check Publication Process status online.
EMail and SMS notification to the author for each Process stage.
Paper and Soft Copy of "Certificate" Available life time on website.

Qualifed & Experience Reviewers from Well-known Institutes/Universities among the world.
Social Media, Email and Call Support 24*7.
Google Scholar, ResearcherID Thomson Reuters Indexing.
Author Research Guidelines & Support.

  Indexing Partners

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
Call For Paper July 2024
Indexing Partner
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
DOI Details

Providing A Free digital object identifier by DOI.one How to get DOI?
For Reviewer /Referral (RMS) Earn 500 per paper
Our Social Link
Open Access
This material is Open Knowledge
This material is Open Data
This material is Open Content
Indexing Partner

Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer